EyePoint Pharmaceuticals (EYPT) Free Cash Flow: 2010-2019
Historic Free Cash Flow for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to -$20.7 million.
- EyePoint Pharmaceuticals' Free Cash Flow fell 20372.55% to -$20.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$46.0 million, marking a year-over-year decrease of 66.93%. This contributed to the annual value of -$130.3 million for FY2024, which is 8001.87% down from last year.
- Latest data reveals that EyePoint Pharmaceuticals reported Free Cash Flow of -$20.7 million as of Q4 2019, which was down 52.99% from -$13.5 million recorded in Q1 2019.
- EyePoint Pharmaceuticals' Free Cash Flow's 5-year high stood at $102,000 during Q4 2018, with a 5-year trough of -$20.7 million in Q4 2019.
- Moreover, its 3-year median value for Free Cash Flow was -$5.5 million (2017), whereas its average is -$8.2 million.
- As far as peak fluctuations go, EyePoint Pharmaceuticals' Free Cash Flow soared by 102.02% in 2018, and later tumbled by 20,372.55% in 2019.
- EyePoint Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$3.2 million in 2015, then tumbled by 56.74% to -$5.0 million in 2016, then fell by 0.48% to -$5.0 million in 2017, then spiked by 102.02% to $102,000 in 2018, then crashed by 20,372.55% to -$20.7 million in 2019.
- Its last three reported values are -$20.7 million in Q4 2019, -$13.5 million for Q1 2019, and $102,000 during Q4 2018.